Literature DB >> 23466270

Incidence of visual impairment over a 20-year period: the Beaver Dam Eye Study.

Ronald Klein1, Kristine E Lee, Ronald E Gangnon, Barbara E K Klein.   

Abstract

PURPOSE: To describe visual impairment (VI) over a 20-year period and its associations with age-related eye diseases and socioeconomic factors in the Beaver Dam Eye Study.
DESIGN: Population-based cohort study. PARTICIPANTS: Four thousand nine hundred twenty-six persons 43 to 86 years of age participated in the baseline examination phase from 1988 through 1990, and 3721, 2962, 2375, and 1913 persons participated in follow-up examinations each spaced 5 years apart from 1993 through 1995, 1998 through 2000, 2003 through 2005, and 2008 through 2010, respectively.
METHODS: Best-corrected visual acuity after refraction, assessed by the Early Treatment Diabetic Retinopathy Study protocol. MAIN OUTCOME MEASURES: Incidence of VI, defined as best-corrected visual acuity of poorer than 20/40 in the better eye in persons with one or both eyes 20/40 or better at the beginning of a 5-year interval, and incidence of severe VI, defined as best-corrected visual acuity of 20/200 or worse in the better eye in persons with one or both eyes better than 20/200 at the beginning of a 5-year interval.
RESULTS: Overall incidence of VI between examinations (5-year interval) was 1.4% (varying from 0.1% in persons 50-54 years of age to 14.6% in those 85 years of age and older), whereas for severe VI it was 0.4% (varying from 0.0% in persons 50-54 years of age to 6.9% in those ≥ 85 years of age). The incidence of VI decreased for each (2003-2005 to 2008-2010; odds ratio fourth interval vs. first interval, 0.53; 95% confidence interval, 0.32-0.87; P = 0.01 period after adjustment for age, from the first 5-year interval between examinations (1988-1990 to 1993-1995) to the fourth and most recent 5-year interval ). This period effect was no longer significant after adjustment for age-related macular degeneration. Age-related macular degeneration remained the leading cause of incident severe VI (54% of eyes with incident severe VI, which was as low as 40% and as high as 57% for specific visits), with no evidence of a trend across visits. The overall frequency of VI correctable with new refraction was 38% of all eyes with VI.
CONCLUSIONS: These data provide population-based estimates that show a high (15%) 5-year incidence of VI in persons 85 years of age and older. Age-related macular degeneration remained the leading cause of severe VI in this population over the 20 years of the study. FINANCIAL DISCLOSURE(S): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Copyright © 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23466270      PMCID: PMC3674166          DOI: 10.1016/j.ophtha.2012.11.041

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  24 in total

Review 1.  Socioeconomic status and blindness.

Authors:  R Dandona; L Dandona
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

2.  Prevalence of age-related maculopathy. The Beaver Dam Eye Study.

Authors:  R Klein; B E Klein; K L Linton
Journal:  Ophthalmology       Date:  1992-06       Impact factor: 12.079

3.  Correctable visual impairment in an older population: the blue mountains eye study.

Authors:  Suriya Foran; Kathryn Rose; Jie Jin Wang; Paul Mitchell
Journal:  Am J Ophthalmol       Date:  2002-11       Impact factor: 5.258

Review 4.  Preferred therapies for neovascular age-related macular degeneration.

Authors:  Allen Chiang; Carl D Regillo
Journal:  Curr Opin Ophthalmol       Date:  2011-05       Impact factor: 3.761

5.  Assessment of cataracts from photographs in the Beaver Dam Eye Study.

Authors:  B E Klein; R Klein; K L Linton; Y L Magli; M W Neider
Journal:  Ophthalmology       Date:  1990-11       Impact factor: 12.079

6.  Blindness and visual impairment in an American urban population. The Baltimore Eye Survey.

Authors:  J M Tielsch; A Sommer; K Witt; J Katz; R M Royall
Journal:  Arch Ophthalmol       Date:  1990-02

7.  Socioeconomic status and visual impairment among urban Americans. Baltimore Eye Survey Research Group.

Authors:  J M Tielsch; A Sommer; J Katz; H Quigley; S Ezrine
Journal:  Arch Ophthalmol       Date:  1991-05

8.  Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study.

Authors:  B Muñoz; S K West; G S Rubin; O D Schein; H A Quigley; S B Bressler; K Bandeen-Roche
Journal:  Arch Ophthalmol       Date:  2000-06

9.  Causes and prevalence of visual impairment among adults in the United States.

Authors:  Nathan Congdon; Benita O'Colmain; Caroline C W Klaver; Ronald Klein; Beatriz Muñoz; David S Friedman; John Kempen; Hugh R Taylor; Paul Mitchell
Journal:  Arch Ophthalmol       Date:  2004-04

10.  The Beaver Dam Eye Study: visual acuity.

Authors:  R Klein; B E Klein; K L Linton; D L De Mets
Journal:  Ophthalmology       Date:  1991-08       Impact factor: 12.079

View more
  32 in total

1.  Photoreceptor dysfunction in early and intermediate age-related macular degeneration assessed with mfERG and spectral domain OCT.

Authors:  Shasha Yang; Chengguo Zuo; Hui Xiao; Lan Mi; Guangwei Luo; Xiaoyu Xu; Xing Liu
Journal:  Doc Ophthalmol       Date:  2016-01-11       Impact factor: 2.379

2.  Oxidized Low-density Lipoprotein and the Incidence of Age-related Macular Degeneration.

Authors:  Ronald Klein; Kristine E Lee; Michael Y Tsai; Karen J Cruickshanks; Ronald E Gangnon; Barbara E K Klein
Journal:  Ophthalmology       Date:  2018-12-17       Impact factor: 12.079

3.  Cigarette smoking and the natural history of age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Chelsea E Myers; Barbara E K Klein; Ronald Gangnon; Theru A Sivakumaran; Sudha K Iyengar; Ronald Klein
Journal:  Ophthalmology       Date:  2014-06-20       Impact factor: 12.079

4.  Five-year incidence, progression, and risk factors for age-related macular degeneration: the age, gene/environment susceptibility study.

Authors:  Fridbert Jonasson; Diana E Fisher; Gudny Eiriksdottir; Sigurdur Sigurdsson; Ronald Klein; Lenore J Launer; Tamara Harris; Vilmundur Gudnason; Mary Frances Cotch
Journal:  Ophthalmology       Date:  2014-04-24       Impact factor: 12.079

5.  Retinal pigmented epithelial cells obtained from human induced pluripotent stem cells possess functional visual cycle enzymes in vitro and in vivo.

Authors:  Tadao Maeda; Mee Jee Lee; Grazyna Palczewska; Stefania Marsili; Paul J Tesar; Krzysztof Palczewski; Masayo Takahashi; Akiko Maeda
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

6.  Does functional assessment predict everyday visual functioning? Visual function testing and quality of life in mild/moderate age-related macular degeneration.

Authors:  Geoffrey K Broadhead; Thomas Hong; John R Grigg; Peter McCluskey; Timothy E Schlub; Kimberly Spooner; Andrew A Chang
Journal:  Int Ophthalmol       Date:  2020-07-14       Impact factor: 2.031

7.  Sunlight exposure, pigmentation, and incident age-related macular degeneration.

Authors:  Barbara E K Klein; Kerri P Howard; Sudha K Iyengar; Theru A Sivakumaran; Kristin J Meyers; Karen J Cruickshanks; Ronald Klein
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-14       Impact factor: 4.799

8.  Longitudinal relationships among visual acuity, daily functional status, and mortality: the Salisbury Eye Evaluation Study.

Authors:  Sharon L Christ; D Diane Zheng; Bonnielin K Swenor; Byron L Lam; Sheila K West; Stacey L Tannenbaum; Beatriz E Muñoz; David J Lee
Journal:  JAMA Ophthalmol       Date:  2014-12       Impact factor: 7.389

9.  Misclassification can explain most apparent regression of age-related macular degeneration: results from multistate models with misclassification.

Authors:  Ronald E Gangnon; Kristine E Lee; Barbara E K Klein; Sudha K Iyengar; Theru A Sivakumaran; Ronald Klein
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

10.  Harmonizing the classification of age-related macular degeneration in the three-continent AMD consortium.

Authors:  Ronald Klein; Stacy M Meuer; Chelsea E Myers; Gabriëlle H S Buitendijk; Elena Rochtchina; Farzana Choudhury; Paulus T V M de Jong; Roberta McKean-Cowdin; Sudha K Iyengar; Xiaoyi Gao; Kristine E Lee; Johannes R Vingerling; Paul Mitchell; Caroline C W Klaver; Jie Jin Wang; Barbara E K Klein
Journal:  Ophthalmic Epidemiol       Date:  2014-02       Impact factor: 1.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.